NCT04163185Phase 3Completed

Initiating Early Control of Migraine Pain and Associated Symptoms

Study sponsor: Axsome Therapeutics, Inc. · AXSM

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2020-03-16Actual

Enrollment · participants302Actual

Source updated2026-01-28Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-01-28 · 1 field changed

Primary completion date changed

− Before

~~23 Mar 2020~~

+ After

16 Mar 2020

Check registry source

Study details

Conditions studied

Migraine

Treatments or interventions studied

AXS-07 (MoSEIC meloxicam and rizatriptan)Drug
PlaceboDrug

Primary outcomes · main study measures

measure: Percentage of Subjects Achieving Headache Pain Freedom at Hour 2; description: Absence of headache pain at Hour 2; timeFrame: Hour 2; measure: Percentage of Subjects With Absence of Most Bothersome Symptom at Hour 2; description: Absence of Most Bothersome Symptom, defined at the onset of migraine at Hour 2; timeFrame: Hour 2

History coverage

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

How to read this history